Japanese health and welfare officials agreed to reimburse healthcare providers for procedures using the TransEnterix (NYSE:TRXC) Senhance robot-assisted surgery device, the company said today. The reimbursement, which became effective yesterday, applies to 98 benign and malignant laparoscopic procedures across general, colorectal, gynecologic, bariatric and urologic surgeries. The reimbursement rates are equivalent to those provided in […]
TransEnterix
TransEnterix deals AutoLap assets for $47m
TransEnterix (NYSE:TRXC) said today that it dealt the AutoLap assets acquired last year along with Medical Surgery Technologies to Great Belief International for $47 million. AutoLap is an image-based scope positioning system for laparoscopic procedures. Last October, Research Triangle Park, N.C.-based TransEnterix paid $5.8 million up front to MST for 3.15 million shares of the Yokneam, Israel-based […]
TransEnterix wins Japanese OK for Senhance in robot-assisted surgery
Japanese regulators approved the Senhance robot-assisted surgery device made by TransEnterix (NYSE:TRXC) for several procedures, the company said today. Japan’s Ministry of Health, Labor & Welfare granted “shonin” approval to Senhance for laparoscopy for general surgery, gynecology, urology and “certain thoracic procedures,” the Research Triangle Park, N.C.-based company said. “Regulatory approval in Japan is a pivotal milestone […]
TransEnterix shares plummet on Q1 sales miss
Shares in TransEnterix (NYSE:TRXC) are down more than 20% after it posted first quarter 2019 earnings that missed wide on sales expectations from analysts on Wall Street. The Research Triangle Park, N.C.-based company posted losses of $22.5 million, or 10¢ per share, on sales of $2.2 million for the three months ended March 31, seeing losses balloon […]
Transenterix shares down on mixed-bag Q4 earnings release
Shares in TransEnterix (NYSE:TRXC) fell today after the medical device maker posted fourth quarter earnings that fell short on loss-per-share expectations but topped sales consensus on Wall Street. The Research Triangle Park, N.C.-based company posted losses of $6.4 million, or 3¢ per share, on sales of $7.5 million for the three months ended December 31, seeing […]
TransEnterix wins FDA clearance for Senhance Ultrasonic
TransEnterix (NYSE:TRXC) said today that it won 510(k) clearance from the FDA for its Senhance Ultrasonic instrument system, designed to operate with its Senhance robot-assisted surgery device. Senhance Ultrasonic instruments are designed to deliver controlled energy to ligate and divide tissue and minimize thermal injury to surrounding structures, Research Triangle Park, N.C.-based TransEnterix said. The instrument set is now […]
Dexcom Q4 prelims top consensus | Wall Street Beat
Dexcom (NSDQ:DXCM) topped estimates on Wall Street today with preliminary results for its fourth-quarter financial results. The San Diego, Calif.-based company said it expects to report $331 million in sales for the quarter ended Dec. 31 – up at least 50% from the same period last year. Get the full story at our sister site, Drug […]
TransEnterix preps for $75m offering
TransEnterix (NYSE:TRXC) is planning for an upcoming $75 million offering, according to a recently posted SEC filing. The Research Triangle Park, N.C.-based company said that Stifel, Nicolaus & Company will serve as its sale agent in the offering, but the company has not yet announced how many shares it plans to float in the sale. The […]
TransEnterix posts Street-beating Q3
TransEnterix (NYSE:TRXC) today posted third quarter earnings that beat expectations on Wall Street. The Research Triangle Park, N.C.-based company posted losses of $20.2 million, or 10¢ per share, on sales of $5.4 million for the three months ended September 30, seeing losses shrink 47.5% while sales grew nearly 3000% compared with the same period during the […]
TransEnterix closes Medical Surgery Technologies buyout
TransEnterix (NYSE:TRXC) has completed its acquisition of all assets, including intellectual property assets of Medical Surgery Technologies (Yokneam, Israel). The terms of the agreement state that the acquisition price will be paid in two tranches. TransEnterix paid $5.8 million to MST and in return received 3.15 million shares of the company’s common stock. One year […]
TransEnterix CEO Pope makes Time’s 50 Most Influential People in Healthcare
TransEnterix (NYSE:TRXC) said today that its president and CEO Todd Pope has been named to Time Magazine’s Most Influential People in Health Care for 2018, highlighted for their work bringing the Senhance robotic surgical platform to the market. Pope was an inaugural selection for the list, which Time Magazine said it assembled to highlight “physicians, scientists, and […]
